Ikko Tomisaki

Publication Activity (10 Years)

Years Active: 2019-2023
Publications (10 Years): 7

Top Topics

Prostate Cancer

Editorial Comment

Radiation Therapy

Top Venues

IJU case reports

International journal of urology : official journal of the Japanese Urological Association

This page only lists publications with an associated author ORCID identifier.

Publications

Ikko Tomisaki, Mirii Harada, Shigeru Sakano, Michikazu Terado, Ryoichi Hamasuna, Shuji Harada, Hiroomi Matsumoto, Soichiro Akasaka, Yujiro Nagata, Akinori Minato, Ken-Ichi Harada, Naohiro Fujimoto
Differential impact of proton pump inhibitor on survival outcomes of patients with advanced urothelial carcinoma treated with chemotherapy versus pembrolizumab. International journal of urology : official journal of the Japanese Urological Association (2023)
Mirii Harada, Ikko Tomisaki, Shohei Shimajiri, Keisuke Kuretake, Kenichi Harada, Naohiro Fujimoto
Small cell carcinoma of the kidney treated with immune checkpoint inhibitor/tyrosine kinase inhibitor. IJU case reports 6 (6) (2023)
Ikko Tomisaki
Editorial Comment to Tri-modality therapy with i-125 brachytherapy, external beam radiation therapy, and short-term hormone therapy for high-risk prostate cancer after holmium laser enucleation of the prostate. IJU case reports 5 (4) (2022)
Ikko Tomisaki
Editorial Comment to A conservative treatment for eosinophilic cystitis. IJU case reports 6 (1) (2022)
Ikko Tomisaki
Editorial Comment to A conservative treatment for eosinophilic cystitis. IJU case reports 6 (1) (2022)
Ikko Tomisaki, Atsuji Matsuyama, Mao Jotatsu, Sohei Yamamura, Rei Onishi, Naohiro Fujimoto
Primary retroperitoneal mucinous cystadenocarcinoma with transition from the mesothelium. IJU case reports 3 (4) (2020)
Ikko Tomisaki
Editorial Comment to Pembrolizumab-induced myasthenia gravis with myositis and presumable myocarditis in a patient with bladder cancer. IJU case reports 3 (1) (2019)